Cancer Drugs

What's Available Now

HERCEPTIN
Action: Antigrowth
Target cancer: Breast cancer
Manufacturer: Genentech
Side effects: Fever and chills; in rare cases, heart problems and potentially fatal allergic reactions
Cost: About $700 for a week's worth of injections. In clinical trials, the median time on Herceptin was 36 weeks.
Total cost: $25,000

RITUXAN
Action: Targeted cell destruction
Target cancer: Non-Hodgkin's lymphoma
Manufacturer: Genentech/IDEC

Want the full story?

Subscribe Now

Subscribe
Subscribe

Learn more about the benefits of being a TIME subscriber

If you are already a subscriber sign up — registration is free!